In focus
Latest feed
Krystal Biotech Soars: RBC Capital Markets Sees Billions in Gene Therapy Potential
Kyverna's KYV-101: A Glimmer of Hope for Lupus Nephritis Patients with Early, Deep Responses, Yet Caution Remains
Akebia Therapeutics Unveils Ambitious Vision for Kidney Disease Innovation at Virtual R&D Day
InflaRx's Vilobelimab: A Deeper Look into Pyoderma Gangrenosum Trial Data
